Noscapine
RESPIRATORY SYSTEM
Also known as: methoxyhydrastine, narcompren, narcosine, noscapalin, noscapin, noscapine HCl, noscapine hydrochloride, terbenol, vadebex
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Noscapine is a drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including CYP2C19, SLC22A2 and CYP2C9.
- Molecular targets: CYP2C19, SLC22A2, CYP2C9 and SLC47A1 (4 listed in DrugCentral).
- ATC code: R05DA07 (Opium alkaloids and derivatives).
- Molecular formula: C22H23NO7; molecular weight 413.43 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Contraindications (25)
- Acute hepatitis
- Alcoholism
- Angina pectoris
- Chronic heart failure
- Continuous fever
- Cor pulmonale
- Cystic fibrosis
- Diabetes mellitus
- Disease of liver
- Hypertensive disorder
- Hyperthyroidism
- Hypothyroidism
- Multiple organ failure
- Myocardial infarction
- Peptic ulcer
- Pulmonary edema
- Seizure disorder
- Sepsis syndrome
- Severe Hypoxemia
- Shock
- Smokes tobacco daily
- Smoking cessation assistance
- Tachyarrhythmia
- Theophylline Toxicity
- Third trimester pregnancy
Mechanism & targets
Molecular targets (4)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Cytochrome P450 2C19 | CYP2C19 | unknown | IC50 6.40 |
| Solute carrier family 22 member 2 | SLC22A2 | unknown | IC50 5.59 |
| Cytochrome P450 2C9 | CYP2C9 | unknown | IC50 5.09 |
| Multidrug and toxin extrusion protein 1 | SLC47A1 | unknown | IC50 4.46 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
R05DA07 | RESPIRATORY SYSTEM › COUGH AND COLD PREPARATIONS › COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS › Opium alkaloids and derivatives |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Toxicity to various agents | 574.7 |
| Drug abuse | 299.9 |
| Intentional product misuse | 118.2 |
| Asphyxia | 118.1 |
| Poisoning | 104.9 |
Chemical structure
| Molecular formula | C22H23NO7 |
|---|---|
| Molecular weight | 413.43 g/mol |
| CAS number | — |
| InChIKey | AKNNEGZIBPJZJG-MSOLQXFVSA-N |
| PubChem CID | 275196 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Noscapine work?
Its molecular targets in DrugCentral include CYP2C19, SLC22A2, CYP2C9 and SLC47A1.
What is the chemical formula of Noscapine?
Noscapine has the molecular formula C22H23NO7 and a molecular weight of 413.43 g/mol.
Browse: all drugs starting with N · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1973 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2106732 — compound record and bioactivity
- PubChem CID 275196 — chemical identifiers
- DrugBank DB06174 — drug record
- FDA UNII 8V32U4AOQU — substance identity
- UniProt P33261 (CYP2C19) — target protein
- UniProt O15244 (SLC22A2) — target protein
- UniProt P11712 (CYP2C9) — target protein
- UniProt Q96FL8 (SLC47A1) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.